Searched for
MSME PHARMACEUTICAL COMPANIES
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIt is probably time to be bullish as an investor. But remember two things. One: Valuations are still not cheap. Two: Because it is over and...- Smaller cities power India’s corporate travel surgeCorporate travel in India is increasingly shifting towards smaller cities, with nearly 60% of bookings now originating from or heading to t...
- While Europe negotiated FTA, this startup was already hosting India's internet economyA new trade deal between India and Europe opens doors for businesses. However, companies like Hostinger from Lithuania already found succes...
- India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- India labour market remodels itself bit by bit as agri slowly cedes ground, workforce moves onIndia's labour market is undergoing a structural transformation driven by the country's broader economic transition, a report by SBI Resear...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Most hated stocks: FIIs dumping these 146 companies without a break for 4 straight quarters. Do you own any?Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...
- Meet the winners of the ET MSME Awards 2025From nanobubble tech and agro-exports to e-waste recycling and specialty chemicals, the best Indian MSMEs across 20 categories redefined wh...
- ET MSME Awards 2025: India's pharma MSMEs face existential choiceNew bio-equivalence rules promise safer drugs but could eliminate pharma manufacturers that make medicines affordable. Is there a middle gr...
- Drug companies flag concerns over timeline for carrying out regulator's manufacturing ruleSmall and medium pharmaceutical companies are appealing to the health minister, raising concerns about stringent manufacturing standards im...
- Many MSME pharma firms making substandard drugs, CDSCO data showsData from the CDSCO reveals that numerous MSME pharmaceutical companies in India are producing substandard drugs, failing to meet safety st...
- Halt inspections, help MSMEs, drug cos' body tells Health minister Mansukh Mandaviya"We had met the minister and urged him to help the MSME sector. We want the officials at the regulatory body to become facilitators for the...
- ET MSME Awards 2023: Apply for any of the 26 MSME award categories to be recognised as a top Indian MSMEET MSME Awards 2023 is an ET Digital initiative aimed at celebrating the success of Indian MSMEs powering the economy. The awards will serv...
- Mandaviya asks MSME pharma firms to move towards good manufacturing practices through self regulationUnion minister, Mansukh Mandaviya, has told representatives of the pharmaceutical industry that Schedule M, which requires adherence to goo...
- Venus Remedies surges 13% on govt's PLI nodIn a release last month, the Ministry of Chemicals and Fertilisers said that 55 companies had qualified for the PLI scheme for the pharmace...
- Another shot for MSMEs to reclaim bankrupt companiesPromoters can be considered for resolution of their own cos as they are exempt from section 29(A) of IBC.
Load More
